Tender detail
Non-exclusive rebate agreement for pegfilgrastim medicines for 2027
Summary
DAK-Gesundheit and the ARGE-OH-BioTech Pegfilgrastim health insurers are seeking non-exclusive rebate agreements for medicines containing pegfilgrastim (ATC L03AA13). The agreements are intended to run from 1 January to 31 December 2027, with an option to extend for 12 months, and will end earlier if an exclusive agreement takes effect.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.